Advertisement
Table 2 Laboratory findings immediately before the administration of intracranial pressure-reducing agents
| Glycerol 200 mL/30 min | Glycerol 200 mL/60 min | Mannitol 300 mL/60 min | P value | |
|---|---|---|---|---|
| WBC, 109/L | 12.5 (10.2–14.7) | 10.1 (9.1–12.2) | 1.4 (8.1–13.4) | 0.228 |
| Hb, g/dL | 9.5 (8.6–11.3) | 8.2 (7.8–10.4) | 9.4 (8.9–10.0) | 0.256 |
| CRP, mg/dL | 8.1 (3.8–14.5) | 5.7 (0.7–9.5) | 5.1 (2.7–9.5) | 0.271 |
| Alb, g/dL | 2.3 (2.1–2.7) | 2.6 (2.3–3.2) | 3.0 (2.5–3.4) | 0.143 |
| BUN, mg/dL | 10 (9–13) | 12 (8–19) | 14 (10–16) | 0.502 |
| Creatinine, mg/dL | 0.67 (0.49–0.87) | 0.51 (0.43–1.11) | 0.61 (0.50–0.97) | 0.790 |
| T-Bil, mg/dL | 0.75 (0.47–1.08) | 0.95 (0.56–1.68) | 1.01 (0.67–1.24) | 0.420 |
| AST, U/L | 28 (18–48) | 26 (21–37) | 29 (23–83) | 0.634 |
| ALT, U/L | 18 (13–37) | 19 (14–43) | 20 (15–57) | 0.699 |
| LDH, U/L | 249 (182–328) | 231 (166–269) | 216 (182–246) | 0.530 |
| P, mg/dL | 2.6 (2.0–2.8) | 2.8 (1.9–3.3) | 2.7 (2.2–3.1) | 0.828 |
| ChE, U/L | 205 (155–234) | 139 (115–185) | 195 (79–232) | 0.211 |
| SOFA | 3 (2–5) | 6 (3–7) | 3 (3–4) | 0.182 |
| Mechanical ventilation | 46.1% | 76.9% | 71.4% | 0.235 |
